Please use this identifier to cite or link to this item:
https://repository.monashhealth.org/monashhealthjspui/handle/1/58218| Title: | Cardiovascular Outcomes with Tirzepatide in Type 2 Diabetes. Reply. | Authors: | Nicholls S.J. ;Pavo I.;D'Alessio D. | Monash Health Department(s): | Cardiology (MonashHeart) | Institution: | (Nicholls) Victorian Heart Institute, Melbourne, VIC, Australia (Pavo) Eli Lilly, Indianapolis, United States (D'Alessio) Duke University Medical Center, Durham, NC, United States |
Issue Date: | 21-Apr-2026 | Copyright year: | 2026 | Place of publication: | United States | Publication information: | The New England journal of medicine. 394(15) (no pagination), 2026. Date of Publication: 16 Apr 2026. | Journal: | The New England Journal of Medicine | DOI: | http://monash.idm.oclc.org/login?url=http://acs.hcn.com.au/?acc=36265&url=https://dx.doi.org/10.1056/NEJMc2600572 | PubMed URL: | 41985147 | URI: | https://repository.monashhealth.org/monashhealthjspui/handle/1/58218 | Type: | Letter | Subjects: | non insulin dependent diabetes mellitus tirzepatide |
| Appears in Collections: | Articles |
Show full item record
Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.